DIMT1P1

Across TCGA pan-cancer cohorts, DIMT1P1 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated DIMT1P1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher DIMT1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DIMT1P1 expression acts as an unfavorable survival marker.

BLCA, STAD, and KIRC are the cancer types where DIMT1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	II,III,IV	0.391	0.621	.010	54	view →
STAD	DFS	Tertile	All	0.453	0.672	.003	54	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
KIRP	OS	Tertile	All	0.199	0.903	<.001	27	view →
BRCA	OS	Tertile	III,IV	0.145	0.548	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

DIMT1P1–BLCA (DFS)

Open the BLCA breakdown →